Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Vivani Medical, Inc.
Report date February 27, 2017 · Filed May 23, 2017
Jointly reported with Alfred E. Mann Living Trust
Section 16 reporting ended · disclosed 2017-05-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Incumed, LLC | 0 |
Last balance in matching sequence
After 2017-04-07 transaction · row 12
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
12 source rowsRow 1 · 2017-02-27 · Sale · Disposed 40,591 · Balance 2,226,145 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 2 · 2017-02-28 · Sale · Disposed 39,028 · Balance 2,187,117 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 3 · 2017-03-01 · Sale · Disposed 44,126 · Balance 2,142,991 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 4 · 2017-03-02 · Sale · Disposed 55,824 · Balance 2,087,167 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 5 · 2017-03-03 · Sale · Disposed 21,715 · Balance 2,065,452 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 6 · 2017-03-06 · Sale · Disposed 113,359 · Balance 1,952,093 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 7 · 2017-03-07 · Sale · Disposed 94,084 · Balance 1,858,009 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 8 · 2017-03-08 · Sale · Disposed 182,917 · Balance 1,675,092 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 9 · 2017-03-09 · Sale · Disposed 105,865 · Balance 1,569,227 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 10 · 2017-03-10 · Sale · Disposed 118,740 · Balance 1,450,487 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.32 to $1.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 11 · 2017-03-13 · Sale · Disposed 23,916 · Balance 1,426,571 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Row 12 · 2017-04-07 · Sale · Disposed 1,426,571 · Balance 0 F14: Private sale to group of individual accredited private investors. F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-07 transaction · row 13
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 13 · 2017-04-07 · Sale · Disposed 5,218,420 · Balance 0 F14: Private sale to group of individual accredited private investors. |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2017-07-31 | Direct | 0 |
Reported balance
After 2017-04-07 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-04-07 · Sale · Disposed 80,000 · Balance 0 F14: Private sale to group of individual accredited private investors. |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2018-02-28 | Direct | 0 |
Reported balance
After 2017-04-07 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2017-04-07 · Sale · Disposed 280,000 · Balance 0 F14: Private sale to group of individual accredited private investors. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.32 to $1.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F14: Private sale to group of individual accredited private investors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 07, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleWarrants to Purchase Common Stock · Derivative | 280,000 | $0.00 Strike: $5.00 | $280.00 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · derivative · entry 15 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 280,000 shares Expires 2018-02-28 F14 · kind: Private sale to group of individual accredited private investors. Read SEC document |
| April 07, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleWarrants to Purchase Common Stock · Derivative | 80,000 | $0.00 Strike: $5.00 | $80.00 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · derivative · entry 14 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2017-07-31 F14 · kind: Private sale to group of individual accredited private investors. Read SEC document |
| April 07, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 5,218,420 | $1.00 | $5,218,420.00 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 13 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F14 · kind: Private sale to group of individual accredited private investors. Read SEC document |
| April 07, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 1,426,571 | $1.00 | $1,426,571.00 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 12 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 0 F14 · kind: Private sale to group of individual accredited private investors. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 13, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 23,916 | $1.38 | $32,999.30 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 11 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 1,426,571 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 10, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 118,740 | $1.38 | $164,348.03 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 10 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 1,450,487 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.32 to $1.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 09, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 105,865 | $1.57 | $166,356.26 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 9 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 1,569,227 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 08, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 182,917 | $1.69 | $308,562.69 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 8 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 1,675,092 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 07, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 94,084 | $1.48 | $139,093.79 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 7 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 1,858,009 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 06, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 113,359 | $1.43 | $162,160.05 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 6 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 1,952,093 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 03, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 21,715 | $1.53 | $33,132.75 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 5 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 2,065,452 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 02, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 55,824 | $1.53 | $85,567.03 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 4 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 2,087,167 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| March 01, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 44,126 | $1.62 | $71,373.81 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 3 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 2,142,991 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| February 28, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 39,028 | $1.65 | $64,364.98 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 2 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 2,187,117 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
| February 27, 2017 Filed May 23, 2017 01:56 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 40,591 | $1.68 | $67,989.93 |
DisclosureSEC source: 0001209191-17-034536 · doc4.xml · nonDerivative · entry 1 Alfred E. Mann Living Trust · CIK 0001678706 · 10% owner Incumed, LLC · CIK 0001678708 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Incumed, LLC Disclosed balance after: 2,226,145 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.